Teva Company

Participants of the Bio-Mix 2022 competition. Photo by Chen Galili

Breast cancer diagnosis using a drop of milk, new treatment for schizophrenia, AI for early diagnosis of diseases

  • No comments
Five projects from universities across the country will compete among themselves in the Bio-Mix 2022 competition. All research has received funding and is accompanied by mentors on behalf of the Teva company as part of a collaboration between the company and the Israeli universities
Teva-Sikor factory in Vilnius. Photo: Rina Yamin

The past, present and future of the Lithuanian biotechnology industry

  • No comments
From the left: Prof. Michel Rebel from the Weizmann Institute, Prof. Vladas Bomlis - Honorary Consul of Lithuania in Israel, CEO of Enterprise Lithuania and next to him the Minister of Economy of Lithuania Rymantas Zhilios at the opening of the Life Sciences Baltics 2012 conference. Photo: Avi Blizovsky

"The 21st century is the century of biotechnology"

  • 3 תגובות
the brain

An important publication for Prof. Amos Korchin

  • 7 תגובות
Dr. Shay Yarkoni, CEO of Bio-Negev

The 'Personalized Medicine' conference is coming to Israel in about a month

  • No comments
Copaxone syringe

The cumulative scope of treatment with Copaxone for the treatment of multiple sclerosis has reached one million patient-years

  • No comments
Cosmic scene with DNA, stars, solvents and atomic circles in oral flow.

PLAC test - a new test to detect hidden risk of heart attack and stroke

  • 6 תגובות
Cosmic scene with DNA, stars, solvents and atomic circles in oral flow.

The New England Journal of Medicine published the successful results of a clinical trial on Teva's Azilact drug

  • One response
Cosmic scene with DNA, stars, solvents and atomic circles in oral flow.

Animal experiments: the story of Copaxone

  • 38 תגובות
Science website logo
SEARCH